Delivery Order SPE2DB22D9316-SPE2DB24FYN69
Award Date 3/22/24
Potential Completion Date 4/12/24
Potential Value $77K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract, valued at $92,844.00, to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of XOLAIR 150 MG/ML SYRINGEML, a specialty pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA, valued at up to $499,999,999, which allows the DLA to issue orders for a wide...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $4,642.20, is for the supply of XOLAIR 150 MG/ML SYRINGEML, a specialty medication. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which allows the...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,321.10, is for the delivery of XOLAIR 75 MG/0.5 ML SYRINGE 0.5ML to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $4,642.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This contract is for the supply of XOLAIR 150 MG/ML SYRINGE, a biologic medication, to support the recurring medical needs of military health facilities. The award is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth up to $3,094.80 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of Xolair 150 mg/mL syringes, with a period of performance through April 18, 2024. This delivery order is part of a larger indefinite delivery vehicle (IDV) contract, number SPE2DB, valued at up to $4,999,999 through the end of 2025, which allows DLA to issue firm fixed-price...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $1,547.40 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of XOLAIR 150 MG/ML SYRINGEML, a pharmaceutical product, with a period of performance through April 2, 2024. This delivery order is issued under a larger indefinite delivery vehicle (IDV) contract, SPE2DB24D9131, held by DMS Pharmaceutical Group with DLA. The IDV...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $18,568.80, is for the delivery of Xolair 150 mg/mL syringes to support the medical supply needs of military health facilities. This order is placed under DMS Pharmaceutical Group's larger indefinite-delivery contract (IDC) with the DLA, valued at up to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $37,137.60 to DMS Pharmaceutical Group Inc., a woman-owned small business in Park Ridge, Illinois. The contract is for the supply of Xolair 150 mg/ml syringes and is part of DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program. This IDC allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical items to...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $9,284.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of XOLAIR 150 MG/ML syringes, with an ultimate completion date of June 6, 2024. This delivery order is placed under DMS Pharmaceutical Group's existing $499,999,999 indefinite delivery contract (IDC) with the DLA, which allows the agency to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $1,547.40 to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract is for the delivery of XOLAIR 150 MG/ML syringes, with a completion date of February 28, 2024. This delivery order is part of a larger indefinite delivery vehicle (IDV) contract, number 4600082013, under the SPE2DB program, which has a total potential value of up to $4,999,999...
- SPE2DB22D9316Indefinite Delivery Contract
- SPE2DB22D9316-SPE2DB24FYN69Delivery Order
The U.S. government's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $77,370.00, is for the delivery of XOLAIR 150 MG/ML SYRINGE/ML to the DLA. This delivery order is part of a larger indefinite delivery vehicle (IDV) contract, SPE2DB, that DMS Pharmaceutical Group holds with the DLA, valued at up to $4,999,999 through the end of 2025. The IDV allows the DLA to issue delivery orders for a broad range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. The contract has no set-aside designation.
Generated 6/21/24, 9:06 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $77.4k | 3/22/24 |